维昇药业-B（02561）于2026年3月4日披露截至2026年2月28日的股份变动月报表。报告显示，公司法定/注册股本维持在500,000,000股，面值为每股0.0001美元，注册股本总额约50,000美元，与上月持平。
截至本月末，公司已发行普通股总数为113,926,864股，较上月底无变化。当月未发生任何新增发行、回购或注销行为，亦无股份期权或股权激励计划导致的股份变动。公司同时确认满足香港联交所上市规则所要求的公众持股量规定。
本次月报显示，公司整体股本结构保持稳定。公告由执行董事卢安邦签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.